FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2154940003> ?p ?o ?g. }

• W2154940003 endingPage "22168" @default.
• W2154940003 startingPage "22165" @default.
• W2154940003 abstract "Stimulation of pheochromocytoma (PC12) cells with the mitogen epidermal growth factor (EGF) produced a rapid and robust accumulation of intracellular reactive oxygen species (ROS), an accumulation which, in other systems, has been shown to be essential for mitogenesis. Brief pretreatment of the cells with nerve growth factor (NGF) suppressed the EGF-mediated ROS increase. EGF failed to produce elevations in ROS in a PC12 variant stably expressing a dominant-negative p21ras construct (PC12-N17) or in cells pretreated with the MEK inhibitor PD098059. NGF failed to suppress the increase in ROS in the PC12 variant nnr5, which lacks p140trk receptors. The suppression of the increase in ROS by NGF was restored in nnr5 cells stably expressing p140trk (nnr5-trk), but NGF failed to prevent the increase in ROS in nnr cells expressing mutant p140trk receptors that lack binding sites for Shc and phospholipase Cγ. Among several inhibitors of superoxide-generating enzymes, only the lipoxygenase inhibitor, nordihydroguaiaretic acid reduced EGF-mediated ROS accumulation. The inhibitory action of NGF on ROS production was mimicked by the nitric oxide donor, sodium nitroprusside, and was blocked by an inhibitor of nitric-oxide synthetase, l-nitroarginine methyl ester. These results suggest a novel mechanism for the rapid interruption of mitogenic signaling by the neurotrophin NGF. Stimulation of pheochromocytoma (PC12) cells with the mitogen epidermal growth factor (EGF) produced a rapid and robust accumulation of intracellular reactive oxygen species (ROS), an accumulation which, in other systems, has been shown to be essential for mitogenesis. Brief pretreatment of the cells with nerve growth factor (NGF) suppressed the EGF-mediated ROS increase. EGF failed to produce elevations in ROS in a PC12 variant stably expressing a dominant-negative p21ras construct (PC12-N17) or in cells pretreated with the MEK inhibitor PD098059. NGF failed to suppress the increase in ROS in the PC12 variant nnr5, which lacks p140trk receptors. The suppression of the increase in ROS by NGF was restored in nnr5 cells stably expressing p140trk (nnr5-trk), but NGF failed to prevent the increase in ROS in nnr cells expressing mutant p140trk receptors that lack binding sites for Shc and phospholipase Cγ. Among several inhibitors of superoxide-generating enzymes, only the lipoxygenase inhibitor, nordihydroguaiaretic acid reduced EGF-mediated ROS accumulation. The inhibitory action of NGF on ROS production was mimicked by the nitric oxide donor, sodium nitroprusside, and was blocked by an inhibitor of nitric-oxide synthetase, l-nitroarginine methyl ester. These results suggest a novel mechanism for the rapid interruption of mitogenic signaling by the neurotrophin NGF. The neurotrophins are a family of polypeptides that are involved in the survival and differentiation of several different classes of neurons in both the central and peripheral nervous systems. Although some aspects of the intracellular mechanisms by which they act are now clear (1Segal R.A. Greenberg M.E. Annu. Rev. Neurosci. 1996; 19: 463-489Crossref PubMed Scopus (904) Google Scholar, 2Kaplan D.R. Miller F.D. Curr. Opin. Cell Biol. 1997; 9: 213-221Crossref PubMed Scopus (545) Google Scholar), the way in which they produce global changes in phenotype, such as differentiation or survival, is not known. One general effect of the neurotrophins on neurons is to inhibit cell division. The mechanisms by which this occurs are a matter of substantial research interest because they may have relevance to the overall control of cell division. It was recently reported that one of the early requirements for the promotion of cell division by mitogenic growth factors involves a rapid intracellular production of reactive oxygen species (ROS), 1The abbreviations used are: ROSreactive oxygen speciesNGFnerve growth factorEGFepidermal growth factorDMEMDulbecco's modified Eagle's mediumDCHF-DAdichlorodihydrofluorescein diacetatel-NAMEl-nitroarginine methyl esterNDGAnordihydroguaiaretic acidNBTnitro blue tetrazoliumSNPsodium nitroprussidePDGFplatelet-derived growth factor.1The abbreviations used are: ROSreactive oxygen speciesNGFnerve growth factorEGFepidermal growth factorDMEMDulbecco's modified Eagle's mediumDCHF-DAdichlorodihydrofluorescein diacetatel-NAMEl-nitroarginine methyl esterNDGAnordihydroguaiaretic acidNBTnitro blue tetrazoliumSNPsodium nitroprussidePDGFplatelet-derived growth factor. such as hydrogen peroxide and superoxide (3Sundaresan M. Yu Z.X. Ferrans V.J. Irani K. Finkel T. Science. 1995; 270: 296-299Crossref PubMed Scopus (2311) Google Scholar, 4Bae Y.S. Kang S.W. Seo M.S. Baines I.C. Tekle E. Chock P.B. Rhee S.G. J. Biol. Chem. 1997; 272: 217-221Abstract Full Text Full Text PDF PubMed Scopus (1097) Google Scholar). In related experiments exogenously added ROS stimulated mitogenesis in various cell types and was associated with increased expression of cellular markers of proliferation (5Guyton K.Z. Liu Y. Gorospe M. Xu Q. Holbrook N.J. J. Biol. Chem. 1996; 271: 4138-4142Abstract Full Text Full Text PDF PubMed Scopus (1139) Google Scholar). Neurotrophin-stimulated production of reactive nitrogen species, such as nitric oxide, is reportedly required for neurotrophin-induced cytostasis and differentiation (6Peunova N. Enikolopov G. Nature. 1995; 374: 68-73Crossref PubMed Scopus (473) Google Scholar). Together these reports suggest that the signal transduction mechanisms leading to either mitogenesis or differentiation may be controlled by the relative balance between distinct forms of oxidant and nitroxide levels within cells. reactive oxygen species nerve growth factor epidermal growth factor Dulbecco's modified Eagle's medium dichlorodihydrofluorescein diacetate l-nitroarginine methyl ester nordihydroguaiaretic acid nitro blue tetrazolium sodium nitroprusside platelet-derived growth factor. reactive oxygen species nerve growth factor epidermal growth factor Dulbecco's modified Eagle's medium dichlorodihydrofluorescein diacetate l-nitroarginine methyl ester nordihydroguaiaretic acid nitro blue tetrazolium sodium nitroprusside platelet-derived growth factor. The PC12 cell model (7Greene L.A. Tischler A.S. Proc. Natl. Acad. Sci. U. S. A. 1976; 73: 2424-2428Crossref PubMed Scopus (4853) Google Scholar, 8Dichter M.A. Tischler A.S. Greene L.A. Nature. 1977; 268: 501-504Crossref PubMed Scopus (288) Google Scholar) has been quite informative in providing an understanding of neurotrophin-induced signal transduction. PC12 cells stimulated with the neurotrophin nerve growth factor (NGF) undergo many of the global changes in phenotype exhibited by normal neurons, including a cessation of cell division. PC12 cells are unique in that they contain functional receptors for the mitogen epidermal growth factor (EGF), as well as for NGF (9Huff K. End D. Guroff G. J. Cell Biol. 1981; 88: 189-198Crossref PubMed Scopus (206) Google Scholar). One way in which the neurotrophins promote cellular differentiation may be to interfere with mitogenic signals. Indeed, previous data from this laboratory suggest that one action of NGF on PC12 cells is the long term down-regulation of mitogen receptors (9Huff K. End D. Guroff G. J. Cell Biol. 1981; 88: 189-198Crossref PubMed Scopus (206) Google Scholar, 10Lazarovici P. Oshima M. Shavit D. Shibutani M. Jiang H. Monshipouri M. Fink D. Movsesyan V. Guroff G. J. Biol. Chem. 1997; 272: 11026-11034Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar). The present experiments demonstrate that NGF also has profound and immediate effects on mitogen signaling. The data show that treatment of PC12 cells with NGF suppresses the increase in ROS produced by the mitogen EGF. Both the increase in ROS produced by EGF and the decrease in ROS produced by NGF appear to be dependent on an intact Ras signal transduction pathway. The generation of ROS produced by EGF is blocked by an inhibitor of lipoxygenase, and the decrease produced by NGF is blocked by an inhibitor of nitric-oxide synthetase. Furthermore, a nitric oxide donor mimicked NGF suppression of ROS. Overall, these data elucidate a mechanism for the acute action of the neurotrophins in blocking signal transduction from mitogen receptors. PC12 cells were cultured in DMEM containing 7% fetal bovine serum, 7% horse serum, 100 μg of streptomycin/ml, and 100 units of penicillin/ml. nnr5 and nnr5 variants were grown in RPMI containing the same additives. One day before each experiment cells were seeded onto collagen-coated 35-mm dishes at a density of 500,000 cells per well in DMEM plus serum, streptomycin, and penicillin as above and allowed to equilibrate overnight. Dichlorodihydrofluorescein diacetate (DCHF-DA; Molecular Probes, Eugene, OR) was dissolved in ethanol and diluted with calcium-free Krebs-Ringer buffer to a final concentration of 5 μm. Cells were loaded with DCHF-DA in Ringer's solution for 5 min, and then the medium was replaced with serum-free DMEM. The fluorescence of intracellular dichlorofluorescein was quantitated by confocal laser scanning fluorescence microscopy (Leica TCS4D, Leica Lasertechnik Heidelberg, Germany) using excitation and emission wavelengths of 488 and 520 nm, respectively. Images were collected using a 512 × 512 pixel format and archived for later analysis. The intensity of the fluorescence in single cells was quantified using Leica quantitation software. For each treatment, three different fields were recorded. The relative fluorescence intensity was measured in 10 cells per field (total: 30 cells per dish) and expressed on a 0- to 255-step gray scale of intensity of fluorescence emission. Two dishes were evaluated in each experiment. EGF and NGF (Collaborative Bioproducts, Boston, MA) were diluted in DMEM and added to cultures at final concentrations of 100 ng/ml each. Sodium nitroprusside and nitro blue tetrazolium (Sigma) were dissolved in sterile H2O. l-NAME (Sigma) was dissolved in ethanol. Diphenyliodonium chloride (Calbiochem), allopurinol (Sigma), PD098095 (2′-amino-3′-methoxyflavone; Calbiochem), and NDGA (Calbiochem) were dissolved in Me2SO. All inhibitors were added to cells 30 min before EGF stimulation. NGF was added either 5 or 10 min before EGF. Treatment of PC12 cells with EGF produced a rapid and robust increase in ROS in the cells (Fig. 1,A and B). Treatment with NGF had no comparable effect (Fig. 1 C), however pretreatment of cells for 10 min with NGF completely abolished the increase in ROS seen upon subsequent treatment with EGF (Fig. 1 E). The EGF-induced increase in ROS appears to require signaling through the Ras pathway. PD098059, a MEK inhibitor, blocked the EGF-induced increase in ROS (Fig. 2 a, A–C) Ras dominant-negative cells (PC12-N17) treated with EGF did not show any increase in ROS (Fig. 2 a,D and E), although, clearly, these cells have EGF receptors (11Shibutani M. Lazarovici P. Johnson A.C. Katagiri Y. Guroff G. J. Biol. Chem. 1998; 273: 6878-6884Abstract Full Text Full Text PDF PubMed Scopus (27) Google Scholar). The NGF-induced decrease in mitogen-generated ROS also appears to depend on the Ras pathway. PC12 nnr5 cells (12Green S.H. Rydel R.E. Connolly J.L. Greene L.A. J. Cell Biol. 1986; 102: 830-843Crossref PubMed Scopus (231) Google Scholar), which lack p140trk receptors for NGF, respond normally to EGF (Fig.2 b, A and B) but are not affected by pretreatment with NGF (Fig. 2 b, C). When p140trk receptors are heterologously expressed in nnr5 cells, the ability of NGF to prevent the EGF-induced rise in ROS is restored (Fig. 2 b, D and E). However PC12 nnr5 cells transfected with a mutant p140trk , which lacks binding sites for PLCγ and for Shc (13Stephens R.M. Loeb D.M. Copeland T.D. Pawson T. Greene L.A. Kaplan D.R. Neuron. 1994; 12: 791-805Abstract Full Text PDF Scopus (471) Google Scholar), and thus do not show NGF-induced activation of the Ras pathway, did not show a suppressive effect of NGF on EGF-induced ROS formation (Fig. 2 b, F and G). The dual reliance of EGF-induced ROS generation and NGF-induced ROS suppression on the Ras pathway is probably predictable; mitogen-induced ROS generation in fibroblasts is suppressed by the expression of dominant-negative isoforms of Ras (14Irani K. Xia Y. Zweier J.L. Sollott S.J. Der C.J. Fearon E.R. Sundaresan M. Finkel T. Goldschmidt-Clermont P.J. Science. 1997; 275: 1649-1652Crossref PubMed Scopus (1431) Google Scholar), and the suppression of endogenous ROS by NGF in GT1-1 trk cells is dependent on the Ras pathway (15Dugan L.L. Creedon D.J. Johnson Jr., E.M. Holtzman D.M. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 4086-4091Crossref PubMed Scopus (120) Google Scholar). It is likely that the species of ROS generated by EGF stimulation is superoxide (O2−). Among a number of drugs that are known to inhibit superoxide-producing enzymes, including NADPH oxidase, cyclooxygenase, and lipoxygenase, only pretreatment of cells with the lipoxygenase inhibitor NDGA suppressed EGF-induced ROS production (Fig.3 a, A–D). In addition, nitro blue tetrazolium (NBT), a specific chemical scavenger of superoxide, suppressed EGF-induced ROS accumulation (Fig. 3 a, E and F). It is also likely that the quenching by NGF pretreatment of the superoxide generated is a result of the production of nitric oxide. Only an inhibitor of nitric-oxide synthetase, l-NAME, prevented the action of NGF (Fig. 3 b, A–F). In addition, the nitric oxide donor sodium nitroprusside (SNP) mimicked the suppressive action of NGF on ROS generation by EGF (Fig.3 b, G and H). It has been shown that nitric oxide will react with superoxide in a highly favorable reaction to produce peroxynitrate anion (OONO−) (16Beckman J.S. Koppenol W.H. Am. J. Physiol. 1996; 271: C1424-C1437Crossref PubMed Google Scholar), which appears to react readily with reduced glutathione (17Quijano C. Alvarez B. Gatti R.M. Augusto O. Radi R. Biochem. J. 1997; 322: 167-173Crossref PubMed Scopus (232) Google Scholar). It is also known that nitric oxide donor compounds inhibit lipoxygenase activity (18Maccarrone M. Corasaniti M.T. Guerrieri P. Nistico G. Agro A.F. Biochem. Biophys. Res. Commun. 1996; 219: 128-133Crossref PubMed Scopus (36) Google Scholar). The data show that EGF treatment of PC12 cells produces a marked increase in ROS, that is likely superoxide, and that NGF produces little or none, despite the data indicating that NGF is initially mitogenic for PC12 cells (19Burstein D.E. Greene L.A. Dev. Biol. 1982; 94: 477-482Crossref PubMed Scopus (76) Google Scholar). Pretreatment with NGF abolishes that increase in a manner dependent upon p140trk . Further, both these actions rely on the integrity of the Ras signal transduction pathway. Finally, the inhibitory action of NGF treatment on ROS accumulation appears to involve the generation of nitric oxide and either the reaction of that nitric oxide with superoxide or the inhibition, by nitric oxide, of lipoxygenase. The acute nature of the response to NGF predicts either a very quick increase in inducible nitric-oxide synthetase or a rapid NGF-induced activation of the constitutive nitric-oxide synthetase, an effect not hitherto reported. It is known that treatment of PC12 cells with NGF leads to a rapid down-regulation of the EGF receptor (20Brown A.B. Carpenter G. J. Neurochem. 1991; 57: 1740-1749Crossref PubMed Scopus (11) Google Scholar, 21Mothe I. Ballotti R. Tartare S. Kowalski-Chauvel A. Van Obberghen E. Mol. Biol. Cell. 1983; 4: 737-746Crossref Scopus (22) Google Scholar). However, it is unlikely that this is the reason for the prevention of the ROS increase by NGF because the down-regulation is only partial and a comparable action of NGF is seen when 3T3 cells transfected with p140trk are treated with PDGF (data not shown), and there is no reason to believe that NGF has any effect on the levels of PDGF receptors in these cells. There is some evidence for the involvement of Ras in ROS generation. In A431 cells, overexpression of Ras was associated with a 40-fold induction in the promoter activity of human 12-lipoxygenase (22Chen B. Liu Y. Yamamoto S. Chang W. Biochim. Biophys. Acta. 1997; 1344: 270-277Crossref PubMed Scopus (21) Google Scholar). Arachidonic acid metabolites produced by lipoxygenase have been reported to be Ras-dependent mitogens for certain cells (23Ralasca M. Silletta M. Carvelli A. Di Francesco A. Fusco A. Ramakrishna V. Corda D. Oncogene. 1995; 10: 2113-2124PubMed Google Scholar) and may also influence Ras-dependent proliferation by modulating its associations with GTPase-activating proteins (24Yu C. Tsai M. Stacey D. Mol. Cell. Biol. 1990; 10: 6683-6689Crossref PubMed Google Scholar, 25Tsai M. Yu C. Wei F. Stacey D. Science. 1989; 243: 522-526Crossref PubMed Scopus (232) Google Scholar). There is only a limited amount of information regarding the involvement of Ras in the regulation of nitric oxide production; lipopolysaccharide induction of nitric-oxide synthetase in astrocytes can be prevented with specific Ras inhibitors (26Pahan K. Sheikh F. Khan M. Namboodiri A. Singh L. J. Biol. Chem. 1998; 273: 2591-2600Abstract Full Text Full Text PDF PubMed Scopus (156) Google Scholar). The generation of ROS is an essential element in signaling from mitogen receptors (3Sundaresan M. Yu Z.X. Ferrans V.J. Irani K. Finkel T. Science. 1995; 270: 296-299Crossref PubMed Scopus (2311) Google Scholar, 4Bae Y.S. Kang S.W. Seo M.S. Baines I.C. Tekle E. Chock P.B. Rhee S.G. J. Biol. Chem. 1997; 272: 217-221Abstract Full Text Full Text PDF PubMed Scopus (1097) Google Scholar). If increases in ROS are prevented the cells neither proliferate nor express normal markers of PDGF-induced mitogenic signaling. Treatment of appropriate cells with neurotrophins inhibits their cell division. The present data indicate that this effect of the neurotrophins is, at least in part, due to their ability to generate nitric oxide which, in turn, quenches the ROS generated by mitogen treatment and thus interrupts the signal transduction pathway that leads to cell division." @default.
• W2154940003 created "2016-06-24" @default.
• W2154940003 creator A5007493545 @default.
• W2154940003 creator A5024335893 @default.
• W2154940003 creator A5025982747 @default.
• W2154940003 creator A5032231073 @default.
• W2154940003 creator A5039089068 @default.
• W2154940003 creator A5051880377 @default.
• W2154940003 creator A5062041588 @default.
• W2154940003 creator A5063592070 @default.
• W2154940003 creator A5071810640 @default.
• W2154940003 date "1998-08-01" @default.
• W2154940003 modified "2023-09-30" @default.
• W2154940003 title "Nerve Growth Factor Treatment Prevents the Increase in Superoxide Produced by Epidermal Growth Factor in PC12 Cells" @default.
• W2154940003 cites W1510592624 @default.
• W2154940003 cites W1761291408 @default.
• W2154940003 cites W1821918060 @default.
• W2154940003 cites W1966821510 @default.
• W2154940003 cites W1970587959 @default.
• W2154940003 cites W1996350615 @default.
• W2154940003 cites W1996649012 @default.
• W2154940003 cites W1998961220 @default.
• W2154940003 cites W2001163784 @default.
• W2154940003 cites W2002566146 @default.
• W2154940003 cites W2010886707 @default.
• W2154940003 cites W2040620685 @default.
• W2154940003 cites W2048569323 @default.
• W2154940003 cites W2055149392 @default.
• W2154940003 cites W2056857208 @default.
• W2154940003 cites W2061001987 @default.
• W2154940003 cites W2067124986 @default.
• W2154940003 cites W2071037043 @default.
• W2154940003 cites W2072569792 @default.
• W2154940003 cites W2077063678 @default.
• W2154940003 cites W2079743245 @default.
• W2154940003 cites W2080669192 @default.
• W2154940003 cites W2104251051 @default.
• W2154940003 cites W2125403403 @default.
• W2154940003 doi "https://doi.org/10.1074/jbc.273.35.22165" @default.
• W2154940003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9712826" @default.
• W2154940003 hasPublicationYear "1998" @default.
• W2154940003 type Work @default.
• W2154940003 sameAs 2154940003 @default.
• W2154940003 citedByCount "69" @default.
• W2154940003 countsByYear W21549400032012 @default.
• W2154940003 countsByYear W21549400032013 @default.
• W2154940003 countsByYear W21549400032014 @default.
• W2154940003 countsByYear W21549400032015 @default.
• W2154940003 countsByYear W21549400032016 @default.
• W2154940003 countsByYear W21549400032017 @default.
• W2154940003 countsByYear W21549400032018 @default.
• W2154940003 countsByYear W21549400032019 @default.
• W2154940003 crossrefType "journal-article" @default.
• W2154940003 hasAuthorship W2154940003A5007493545 @default.
• W2154940003 hasAuthorship W2154940003A5024335893 @default.
• W2154940003 hasAuthorship W2154940003A5025982747 @default.
• W2154940003 hasAuthorship W2154940003A5032231073 @default.
• W2154940003 hasAuthorship W2154940003A5039089068 @default.
• W2154940003 hasAuthorship W2154940003A5051880377 @default.
• W2154940003 hasAuthorship W2154940003A5062041588 @default.
• W2154940003 hasAuthorship W2154940003A5063592070 @default.
• W2154940003 hasAuthorship W2154940003A5071810640 @default.
• W2154940003 hasBestOaLocation W21549400031 @default.
• W2154940003 hasConcept C134018914 @default.
• W2154940003 hasConcept C170493617 @default.
• W2154940003 hasConcept C181199279 @default.
• W2154940003 hasConcept C185592680 @default.
• W2154940003 hasConcept C2775960820 @default.
• W2154940003 hasConcept C2776362946 @default.
• W2154940003 hasConcept C2778423431 @default.
• W2154940003 hasConcept C2780795997 @default.
• W2154940003 hasConcept C55493867 @default.
• W2154940003 hasConcept C86803240 @default.
• W2154940003 hasConcept C95444343 @default.
• W2154940003 hasConceptScore W2154940003C134018914 @default.
• W2154940003 hasConceptScore W2154940003C170493617 @default.
• W2154940003 hasConceptScore W2154940003C181199279 @default.
• W2154940003 hasConceptScore W2154940003C185592680 @default.
• W2154940003 hasConceptScore W2154940003C2775960820 @default.
• W2154940003 hasConceptScore W2154940003C2776362946 @default.
• W2154940003 hasConceptScore W2154940003C2778423431 @default.
• W2154940003 hasConceptScore W2154940003C2780795997 @default.
• W2154940003 hasConceptScore W2154940003C55493867 @default.
• W2154940003 hasConceptScore W2154940003C86803240 @default.
• W2154940003 hasConceptScore W2154940003C95444343 @default.
• W2154940003 hasIssue "35" @default.
• W2154940003 hasLocation W21549400031 @default.
• W2154940003 hasOpenAccess W2154940003 @default.
• W2154940003 hasPrimaryLocation W21549400031 @default.
• W2154940003 hasRelatedWork W1996649012 @default.
• W2154940003 hasRelatedWork W1999660566 @default.
• W2154940003 hasRelatedWork W2065662041 @default.
• W2154940003 hasRelatedWork W2110262055 @default.
• W2154940003 hasRelatedWork W2144562624 @default.
• W2154940003 hasRelatedWork W2154940003 @default.
• W2154940003 hasRelatedWork W2171223757 @default.
• W2154940003 hasRelatedWork W2770236606 @default.
• W2154940003 hasRelatedWork W4236934633 @default.

• next